Working memory failure by combined blockade of muscarinic and beta-adrenergic transmission in the rat hippocampus

Neuroreport
M OhnoS Watanabe

Abstract

INTRAHIPPOCAMPAL administration of the muscarinic acetylcholine receptor antagonist scopolamine at a dose of 3.2 micrograms/side significantly increased the number of errors (attempts to pass through two incorrect panels of the three panel-gates at four choice points) in the working memory task with a three-panel runway setup, whereas 0.32 microgram/side scopolamine did not affect working memory errors. The beta-adrenoceptor antagonist propranolol (10 mg/kg, i.p.) had no effect on working memory error, but it produced a significant increase in working memory errors when administered in combination with intrahippocampal scopolamine at the behaviourally ineffective dose (0.32 microgram/side). The increase in working memory errors induced by intrahippocampal administration of 0.32 microgram/side scopolamine to rats treated with 10 mg/kg propranolol was decreased by concurrent injection of the cholinesterase inhibitor physostigmine (3.2 micrograms/side). D-Cycloserine (the partial agonist at the glycine bindings site on the NMDA receptor/channel complex) at a dose of 10 micrograms/side reduced the increase in working memory errors induced by intrahippocampal 0.32 microgram/side scopolamine combined with 10 mg/kg propranolol. These ...Continue Reading

References

Jan 1, 1990·Pharmacology·C A Bruner, R C Webb
Jan 7, 1993·Nature·T V Bliss, G L Collingridge

❮ Previous
Next ❯

Citations

Dec 25, 2002·Clinical Biochemistry·Stylianos TsakirisGeorge A Karikas
Nov 26, 1998·Progress in Neuro-psychopharmacology & Biological Psychiatry·J L Giacchino, S J Henriksen
May 29, 1998·Progress in Neurobiology·N J Woolf
Dec 16, 1998·Neuroscience Letters·V RevillaA Fernández-López
Sep 2, 1999·Neuroscience Letters·V RevillaA Fernández-López
May 1, 2002·Behavioural Pharmacology·N De-Mello, A P Carobrez
Jan 30, 2004·Learning & Memory·Marise B Parent, Mark G Baxter
Jan 26, 2010·European Journal of Pharmacology·Akiko OkadaChiaki Kamei
Jun 30, 2000·Neurobiology of Learning and Memory·D A CzechK K Laubmeier
Apr 10, 1999·Neurobiology of Learning and Memory·D MenP E Gold
Jan 27, 2005·Journal of Psychopharmacology·Ulrich MüllerPeter Bublak
Jan 23, 2018·The Journal of Comparative Neurology·Roberta PintusGiampiero Leanza
Aug 22, 2021·Behavioural Pharmacology·Stephanie L GrellaDiano F Marrone

❮ Previous
Next ❯

Related Concepts

Related Feeds

Adrenergic Receptors: Trafficking

Adrenergic receptor trafficking is an active physiological process where adrenergic receptors are relocated from one region of the cell to another or from one type of cell to another. Discover the latest research on adrenergic receptor trafficking here.